1.06
price up icon0.00%   0.00
after-market 시간 외 거래: 1.04 -0.02 -1.89%
loading
전일 마감가:
$1.06
열려 있는:
$1.08
하루 거래량:
2.60M
Relative Volume:
0.75
시가총액:
$47.08M
수익:
-
순이익/손실:
$-51.50M
주가수익비율:
-0.265
EPS:
-4
순현금흐름:
$-47.10M
1주 성능:
+9.14%
1개월 성능:
+24.53%
6개월 성능:
-13.11%
1년 성능:
-80.15%
1일 변동 폭
Value
$1.04
$1.11
1주일 범위
Value
$0.928
$1.1899
52주 변동 폭
Value
$0.79
$6.98

아웃룩 테라퓨틱스 Stock (OTLK) Company Profile

Name
명칭
Outlook Therapeutics Inc
Name
전화
(609) 619-3990
Name
주소
111 S. WOOD AVENUE, ISELIN, NJ
Name
직원
23
Name
트위터
Name
다음 수익 날짜
2024-08-14
Name
최신 SEC 제출 서류
Name
OTLK's Discussions on Twitter

OTLK을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
OTLK
Outlook Therapeutics Inc
1.06 47.08M 0 -51.50M -47.10M -4.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

아웃룩 테라퓨틱스 Stock (OTLK) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-08-29 다운그레이드 H.C. Wainwright Buy → Neutral
2025-08-28 다운그레이드 Guggenheim Buy → Neutral
2024-12-02 다운그레이드 Chardan Capital Markets Buy → Neutral
2024-03-27 업그레이드 BTIG Research Neutral → Buy
2024-02-15 업그레이드 Chardan Capital Markets Neutral → Buy
2024-01-25 업그레이드 Guggenheim Neutral → Buy
2023-12-27 업그레이드 CapitalOne Equal Weight → Overweight
2023-08-31 다운그레이드 Chardan Capital Markets Buy → Neutral
2023-08-31 다운그레이드 H.C. Wainwright Buy → Neutral
2023-08-30 다운그레이드 BTIG Research Buy → Neutral
2023-08-30 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2023-08-30 다운그레이드 CapitalOne Overweight → Equal Weight
2023-08-30 다운그레이드 Guggenheim Buy → Neutral
2023-07-13 개시 CapitalOne Overweight
2023-04-03 개시 Guggenheim Buy
2023-02-06 개시 Cantor Fitzgerald Overweight
2022-10-31 개시 BTIG Research Buy
2022-09-13 개시 Chardan Capital Markets Buy
2019-09-11 개시 Ladenburg Thalmann Buy
2019-05-16 개시 Oppenheimer Outperform
2019-04-22 개시 Ascendiant Capital Markets Buy
모두보기

아웃룩 테라퓨틱스 주식(OTLK)의 최신 뉴스

pulisher
Sep 30, 2025

Can Outlook Therapeutics Inc. stock continue upward trendWeekly Profit Analysis & Weekly High Momentum Picks - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

OTLK Receives Neutral Rating from HC Wainwright & Co. | OTLK Sto - GuruFocus

Sep 30, 2025
pulisher
Sep 30, 2025

H.C. Wainwright maintains Neutral rating on Outlook Therapeutics stock - Investing.com India

Sep 30, 2025
pulisher
Sep 30, 2025

Is Outlook Therapeutics Inc. (41ON) stock good for long term investing2025 EndofYear Setup & Technical Confirmation Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Outlook Therapeutics plans FDA BLA resubmission for wet AMD treatment By Investing.com - Investing.com Nigeria

Sep 30, 2025
pulisher
Sep 29, 2025

What analysts say about Outlook Therapeutics Inc stockBlue Chip Stock Analysis & Discover Stocks Experts Are Watching - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics stock price target raised to $13 from $8 at Brookline Capital - Investing.com Nigeria

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics Completes FDA Meeting on ONS-5010 - TipRanks

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics Plans to Resubmit ONS-5010 Biologics License Application Before Year-End - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics Stock: To Buy or Not? - StocksToTrade

Sep 29, 2025
pulisher
Sep 29, 2025

Why Outlook Therapeutics Inc. (41ON) stock is favored by hedge fundsWeekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

How to recover losses in Outlook Therapeutics Inc. stockTrade Exit Report & AI Powered Market Trend Analysis - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics stock surges after productive FDA meeting By Investing.com - Investing.com Nigeria

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics stock surges after productive FDA meeting - Investing.com India

Sep 29, 2025
pulisher
Sep 29, 2025

Can Outlook Therapeutics Inc. rally from current levelsTrade Analysis Report & Momentum Based Trading Ideas - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

What is the fair value of Outlook Therapeutics Inc. stock nowGold Moves & Low Drawdown Momentum Trade Ideas - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

How Outlook Therapeutics Inc. (41ON) stock moves in volatile trading sessions - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics (OTLK) Engages in Constructive Talks with F - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics (OTLK) Aims for BLA Resubmission by Year-En - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics provides update on Type A Meeting with FDA - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Is Outlook Therapeutics Inc. (41ON) stock attractive for growth fundsOptions Play & Verified Swing Trading Watchlist - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics plans FDA BLA resubmission for wet AMD treatment - Investing.com India

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics Provides Update On Type A Meeting With FDA - TradingView

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics Provides Update on Type A Meeting with FDA - GlobeNewswire

Sep 29, 2025
pulisher
Sep 29, 2025

How Outlook Therapeutics Inc. (41ON) stock expands through international marketsJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Outlook Therapeutics, Inc. Announces Type A Meeting with the U.S. Food and Drug Administration Resubmission for Ons-5010 - MarketScreener

Sep 29, 2025
pulisher
Sep 28, 2025

Market reaction to Outlook Therapeutics Inc.’s recent newsJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

What drives Outlook Therapeutics Inc 41ON stock priceFundamental Stock Analysis & Easy Tools to Analyze Your Investment Risk - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

How Outlook Therapeutics Inc. stock performs in interest rate cyclesJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com

Sep 28, 2025
pulisher
Sep 22, 2025

OTLK: Ascendiant Capital Lowers Price Target While Maintaining B - GuruFocus

Sep 22, 2025
pulisher
Sep 21, 2025

Outlook Therapeutics, Inc.(NasdaqCM: OTLK) dropped from S&P Global BMI Index - MarketScreener

Sep 21, 2025
pulisher
Sep 20, 2025

IPO Launch: What is RIBBR’s valuation compared to sectorWall Street Watch & Pattern Based Trade Signal System - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Exit Recap: Is Outlook Therapeutics Inc. stock trending bullishEarnings Miss & Capital Efficient Trading Techniques - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

What data driven models say about Outlook Therapeutics Inc.’s future2025 Top Decliners & Reliable Price Breakout Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Sentiment Watch: Is Outlook Therapeutics Inc. showing insider buying2025 EndofYear Setup & Short-Term High Return Strategies - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Performance Recap: Is Outlook Therapeutics Inc a top pick in the sector2025 Valuation Update & Weekly Watchlist for Consistent Profits - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Applying sector rotation models to Outlook Therapeutics Inc.Take Profit & Verified Momentum Watchlists - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

Short interest data insights for Outlook Therapeutics Inc.Long Setup & Advanced Technical Analysis Signals - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Published on: 2025-09-19 03:10:54 - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Breakout Move: Is Outlook Therapeutics Inc forming a bullish divergenceLayoff News & Free Accurate Trade Setup Notifications - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Largest borrow rate increases among liquid names - TipRanks

Sep 17, 2025
pulisher
Sep 17, 2025

Bull Bear: Does Outlook Therapeutics Inc have consistent dividend growthProduct Launch & Weekly Stock Breakout Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Growth Recap: Can Outlook Therapeutics Inc. navigate macro headwindsBear Alert & Real-Time Price Movement Reports - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Summary: Does Outlook Therapeutics Inc have strong EBITDA margins2025 Trading Volume Trends & Weekly High Return Forecasts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Movement Recap: Should you buy the dip on Outlook Therapeutics IncTrade Ideas & Weekly Top Gainers Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Is Senseonics Holdings Inc forming bullish engulfing patternsPortfolio Profit Report & Fast Gaining Stock Reports - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

AI Stocks: How does Outlook Therapeutics Inc perform in inflationary periodsTrade Entry Report & Fast Momentum Stock Entry Tips - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

VIX Spike: Is Outlook Therapeutics Inc a top pick in the sectorJuly 2025 WrapUp & Capital Efficiency Focused Strategies - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Sentiment Watch: Is Outlook Therapeutics Inc in a long term uptrend2025 Volume Leaders & High Yield Equity Trading Tips - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Dip Buying: Is Outlook Therapeutics Inc forming a bullish divergenceWeekly Gains Report & Verified Entry Point Detection - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Aug EndMonth: Will Outlook Therapeutics Inc benefit from government policySwing Trade & Low Risk Entry Point Guides - خودرو بانک

Sep 16, 2025

아웃룩 테라퓨틱스 (OTLK) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
자본화:     |  볼륨(24시간):